The Brazilian Health Regulatory Agency (Anvisa) announced on Saturday that it had returned a request for the emergency use of Sputnik V to the applicant, pharmaceutical company Uniao Quimica. The paperwork submitted by the firm did not meet the “minimum requirements for submission and analysis by Anvisa,” the regulator said. …
Read More »Reports that Brazil rejected Russian Covid-19 vaccine are ‘inaccurate’, Sputnik V sponsor says, after approval hiccup
